Jumpertz von Schwartzenberg, Reiner
Vazquez Arreola, Elsa
Sandforth, Arvid
Hanson, Robert L.
Birkenfeld, Andreas L.
Funding for this research was provided by:
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Article History
Received: 13 February 2024
Accepted: 15 April 2024
First Online: 23 May 2024
Acknowledgements
: The DPP was conducted by the DPP Research Group and supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), General Clinical Research Centers Program, National Institute of Child Health and Human Development, National Institute on Aging, Office of Research on Women’s Health, Office of Research and Minority Health, Centers for Disease Control and Prevention and ADA. The data (and samples) from the DPP were supplied by the NIDDK Central Repository. This manuscript was not prepared under the auspices of the DPP and does not represent analyses or conclusion of the DPP Research Group, the NIDDK Central Repository or the National Institutes for Health.
: The Diabetes Prevention Program (DPP) data reported here are available on request at the US National Institute of Diabetes and Digestive and Kidney Diseases Central Repository website ().
: Open Access funding enabled and organized by Projekt DEAL. The analysis included in this article was supported by the Intramural Research Program of the NIDDK. The DPP was supported by the NIDDK and other agencies. Additionally the analysis was funded by the German Federal Ministry for Education and Research (01GI0925) through the DZD; Ministry of Science, Research and the Arts Baden-Württemberg and Helmholtz Munich. ALB was supported by research grants from the German Research Foundation (GRK2816; BI 1292/9-1; BI 1292/10-1; BI 1292/12-1). RJvS was funded by Helmholtz Munich and the Helmholtz Association through a Helmholtz Young Investigator Group (VH-NG-1619) and by the Cluster of Excellence (EXC-2124/1-03.007). The study funder was not involved in the design of the study; the collection, analysis and interpretation of data; or writing the report; and did not impose any restrictions regarding the publication of the report.
: ALB has received lecture/advisory board fees from Bayer; and lecture fees from Novo Nordisk, Boehringer Ingelheim, Daiichi Sankyo and Eli Lilly paid to University Hospital Tübingen. ALB is a co-founder of Eternygen GmbH.
: ALB conceptualised the details of the analysis and interpreted the data. RJvS, EVA, AS and RLH analysed and interpreted the data. ALB wrote the manuscript and RJvS, EVA, RLH and AS critically edited the manuscript. All authors approved the final version for publication. ALB is the guarantor of this work.